NCT05273606

Brief Summary

The study is aimed to observe the short-term clinical performance of MiSight™ multifocal soft contact lens compared with Proclear™ 1day, including objective examination, subjective acceptability of wearers, and doctors' evaluation of the clinical manifestations of lenses.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 10, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

July 16, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2022

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2022

Completed
Last Updated

December 28, 2022

Status Verified

December 1, 2022

Enrollment Period

5 months

First QC Date

February 28, 2022

Last Update Submit

December 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the contrast sensitivity visual function (CSF) relative to baseline at 1 month

    Proclear baseline;VMisight baseline; 1 week; 1month

Secondary Outcomes (3)

  • Patients' subjective acceptability to multifocal soft contact lens

    Proclear baseline; Misight baseline; 1 week; 1month

  • Doctors' clinical evaluation to multifocal soft contact lens

    Proclear baseline; Misight baseline; 1 week; 1month

  • Change in the contact lens corrected visual acuity relative to baseline

    Proclear baseline;Misight baseline;1 week;1month

Study Arms (1)

Experimental Group

EXPERIMENTAL

one group for contact lens

Device: MiSight mutifocal soft contact lensDevice: Proclear 1 Day soft contact lens

Interventions

Subjects will wear MiSight™ multifocal soft contact lenses for 1 month.

Experimental Group

Proclear™ 1 Day soft contact lens will be worn for baseline evaluation.

Experimental Group

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Prior to being considered eligible to participate in this study, each subject MUST:
  • Be between 8 and 12 years of age inclusive at the baseline examination.
  • Have:
  • read the Informed Assent,
  • been given an explanation of the Informed Assent,
  • indicated an understanding of the Informed Assent and
  • signed the Informed Assent Form.
  • Have their parent or legal guardian:
  • read the Informed Consent,
  • been given an explanation of the Informed Consent,
  • indicated an understanding of the Informed Consent and
  • signed the Informed Consent Form.
  • Along with their parent or guardian, be capable of comprehending the nature of the study and be willing and able to adhere to the instructions set forth in this protocol.
  • Along with their parent or guardian, agree to maintain the visit schedule and be able to keep all appointments as specified in the study protocol for the duration of the study.
  • Agree to wear the assigned contact lenses for the duration of the 1-month study and to inform the study investigator if this schedule is interrupted. (Wearing time may be modified by the study staff for health reasons.)
  • +5 more criteria

You may not qualify if:

  • Subjects may not be considered eligible if ANY of the following apply:
  • Subject has regular use of ocular medications.
  • Any systemic disease which is not suggested to wear contact lens or current use of systemic medications which may significantly affect contact lens wear, visual function, or refractive state.
  • A history of ocular trauma or ocular surgery in the last 8 weeks.
  • Subject has worn rigid gas permeable contact lenses in the last 6 weeks, including orthokeratology lenses.
  • Abnormal secretion or excretion of tear fluid, infection of the tear ducts, or other recurrent ocular infections.
  • A known allergy to fluorescein, benoxinate, proparacaine, or tropicamide.
  • Keratoconus or an irregular cornea.
  • Subjects who have been in a special environment such as dryness, serious dust, or volatile chemicals for a long time affect the wear of contact lenses.
  • Strabismus, amblyopia patients, only one eye meets the admission conditions.
  • Subjects have received any myopia control treatment.
  • Subject is currently an active participant in another clinical study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, 510060, China

Location

MeSH Terms

Conditions

Myopia

Interventions

Contact Lenses, Hydrophilic

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

Contact LensesLensesOptical DevicesEquipment and Supplies

Study Officials

  • Xiao Yang, PhD

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

February 28, 2022

First Posted

March 10, 2022

Study Start

July 16, 2022

Primary Completion

December 13, 2022

Study Completion

December 16, 2022

Last Updated

December 28, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations